In order to ensure that you continue to receive information that is of interest from PharmaVentures help us by subscribing. Thank you for your co-operation. New PharmaVentures Reports 30% off introductory offer on the updated 2005 Effective Licensing Report This report provides a concise and focused means of assessing and benchmarking drug delivery deals over the past 8 years. Detailing valuation methodologies and exploring effective deal structures, this report is critical for all those involved in deal making. Order your copy before the 29th April at the special introductory rate. Read more... Nanotechnology-Based Drug Delivery Systems in Japan Ensure that you are informed about all the latest Nanotechnology developments taking place in Japan. This new report is based on a 4 month study of the Japanese market and summarises information obtained from a wide variety of sources. Read more... Market News and Trends In March, PharmaDeals® Agreements reported two deals by Endo Pharmaceuticals, a specialty pharmaceutical company with a strong focus in pain management, involving the licensing rights of transdermal patches with ProEthic Pharmaceuticals, Inc. and DURECT Corporation. Read more... Featured Article Soft Mist Inhalers: A Review of Current Technology Michael Hindle (Virginia Commonwealth University) discusses four major development efforts that are currently ongoing in the area of soft mist inhalers. In this review, the common characteristics of these aerosol inhalers will be described together with a review of published data for some inhalers currently in use. Read more... Company Profiles Aegis Therapeutics, Alkermes, MedPharm, Pfeiffer Drug Delivery Opportunities New Opportunity Drug Delivery Across Blood Brain Barriers Administrative route - Intravenous Indication - Undisclosed Licence code LO-0405-01 To profile your own opportunities, request a password or alternatively view all our drug delivery opportunities online. New Spring/Summer 2005 Drug Delivery Report published May 2005! Make sure you receive your copy of the Spring/Summer 2005 Drug Delivery Report by applying online. Alternatively you can find out about the Autumn/Winter edition.
Drug Delivery E-News is produced by PharmaVentures Intelligence, part of PharmaVentures - a leading results driven organisation assisting pharmaceutical and biotechnology companies worldwide in all aspects of deal making. Comprising two specialist areas - PharmaVentures Consulting and PharmaVentures Intelligence, we work with clients to drive greater value from their deals. If you do not wish to receive E-News in future, please email ddcr@pharmamail.biz with the words UNSUBSCRIBE as the subject. If you do not wish to receive other e-mail communications from PharmaVentures or selected third parties, please e-mail ddcr@pharmamail.biz with REMOVE as the subject. For more details contact Mel Hemamda, Product Manager, PharmaVentures Ltd, Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, UK. Tel: +44 (0) 1865 784 177 Fax: +44 (0) 1865 784 178 E-mail enquiries@ddcr.com www.ddcr.com